The Egyptian Cabinet’s Media Center has responded to circulating claims regarding reports of counterfeit breast cancer medications in the local market. In a statement released Wednesday, the Center clarified that the reports concerning the oncology drug “Ibrance™ (palbociclib) 125 mg capsules” do not pertain to the Egyptian market, but are for another country. The Center … The post No counterfeit drugs detected in local markets: EDA confirms appeared first on Egypt Independent .